Akèy › Dyabèt Tip 2 › Virginia
Etid klinik pou Dyabèt Tip 2 nan Virginia
26 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
- Arlington15 etid
- Richmond5 etid
- Alexandria5 etid
- Norfolk5 etid
- Newport News4 etid
- Roanoke3 etid
- Charlottesville3 etid
Tèks ofisyèl etid la (Anglè)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Carient Heart & Vascular - Manassas, Manassas
- Carient Heart and Vascular LLC-Reston, Reston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Tidewater Physicians Multispecialty Group, Newport News
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Seven Corners Medical Center, Falls Church
- Carient Heart and Vascular, Manassas
- York Clinical Research, Norfolk
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Tidewater Physicians Multispecialty Group, Newport News
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chippenham Johnston Willis Medical Center, Richmond
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- York Clinical Research, LLC, Norfolk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Manassas
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Manassas
- Research Site, Norfolk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Hampton
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450Cooking Health-Oriented Meals to Prevent Dementia and Diabetes
- Virginia Tech, Blacksburg
Ap rekriteVolontè an sante akeyi
Laj 50 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT07661368A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Conquest Research - Arlington, Vienna
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
- Centricity Research Suffolk Primary Care, Suffolk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Leesburg
- Research Site, Norfolk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Suffolk, Suffolk
- Conquest Research, Vienna
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UVA Health Systems, Charlottesville
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
- Clinical Research Partners, LLC, Richmond
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Manassas Clinical Research Center Inc, Manassas
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Carient Heart and Vascular, Manassas
- Dominion Medical Associates, Richmond
- VA Medical Center_Salem, Salem
- ak 1 plis
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Arlington
- Research Site, Newport News
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Manassas Clinical Research Center, Manassas
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Riverside Family Medicine Residency Program, Newport News
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Burke Internal Medicine and Research, Burke
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Burke Internal Medicine & Research, Burke
- Tekton Research, Midlothian
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
- University of Virginia Center for Diabetes Technology, Charlottesville
Ap rekrite
Laj 30 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT05766735Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- University of Virginia, Charlottesville
Ap rekriteVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Mar 23, 2026 · NCT04791371Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Foot and Ankle Specialists of the Mid-Atlantic, Salem
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT06681428Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.